I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Case report: ex vivo tumor organoid drug testing identifies..:
Marwah Al-Aloosi
;
Amanda M. Prechtl
;
Payel Chatterjee
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1267650/full. , 2024
Link:
https://doi.org/10.3389/fonc.2023.1267650
RT Journal T1
Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:fcc76ebb292445b4b3f929be800bb6b7&Exemplar=1&LAN=DE A1 Marwah Al-Aloosi A1 Amanda M. Prechtl A1 Payel Chatterjee A1 Brady Bernard A1 Christopher J. Kemp A1 Rachele Rosati A1 Robert L. Diaz A1 Lauren R. Appleyard A1 Shalini Pereira A1 Alex Rajewski A1 Amber McDonald A1 Eva J. Gordon A1 Carla Grandori PB Frontiers Media S.A. YR 2024 K1 low grade serous ovarian cancer K1 functional precision medicine K1 tumor organoids K1 medium-throughput drug screen K1 fulvestrant K1 everolimus K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1267650/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1267650 DO https://doi.org/10.3389/fonc.2023.1267650 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)